Clinical Trial Update: A Study to Learn About How a New Pneumococcal Vaccine Works in Children [Phase 2]

View source ↗

Summary

Pfizer completed a Phase 2 trial in children evaluating a new pneumococcal vaccine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Disease

Drugs mentioned

• Pneumococcal vaccine (pneumococcal vaccine)

Snippet

Sponsor: Pfizer | Conditions: Pneumococcal Disease | Phase 2 | Status: COMPLETED